BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37369132)

  • 1. Expression and prognostic role of STAT5a across cancer types.
    Maninang C; Li J; Li WX
    Biosci Rep; 2023 Aug; 43(8):. PubMed ID: 37369132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signal transducer and activator of transcription 5a/b: biomarker and therapeutic target in prostate and breast cancer.
    Koptyra M; Gupta S; Talati P; Nevalainen MT
    Int J Biochem Cell Biol; 2011 Oct; 43(10):1417-21. PubMed ID: 21704724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signal transducer and activator of transcription 5A/B in prostate and breast cancers.
    Tan SH; Nevalainen MT
    Endocr Relat Cancer; 2008 Jun; 15(2):367-90. PubMed ID: 18508994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low levels of Stat5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomes.
    Peck AR; Witkiewicz AK; Liu C; Klimowicz AC; Stringer GA; Pequignot E; Freydin B; Yang N; Ertel A; Tran TH; Girondo MA; Rosenberg AL; Hooke JA; Kovatich AJ; Shriver CD; Rimm DL; Magliocco AM; Hyslop T; Rui H
    Breast Cancer Res; 2012 Oct; 14(5):R130. PubMed ID: 23036105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Notch3 restricts metastasis of breast cancers through regulation of the JAK/STAT5A signaling pathway.
    Chen MN; Fang ZX; Wu Z; Bai JW; Li RH; Wen XF; Zhang GJ; Liu J
    BMC Cancer; 2023 Dec; 23(1):1257. PubMed ID: 38124049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased expression of STAT5A predicts poor prognosis in osteosarcoma.
    Guo Z; Tang Y; Fu Y; Wang J
    Pathol Res Pract; 2019 Mar; 215(3):519-524. PubMed ID: 30638860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The transcriptional STAT3 is a potential target, whereas transcriptional STAT5A/5B/6 are new biomarkers for prognosis in human breast carcinoma.
    Wu HT; Liu J; Li GW; Shen JX; Huang YT
    Oncotarget; 2017 May; 8(22):36279-36288. PubMed ID: 28422733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolactin inhibits BCL6 expression in breast cancer through a Stat5a-dependent mechanism.
    Tran TH; Utama FE; Lin J; Yang N; Sjolund AB; Ryder A; Johnson KJ; Neilson LM; Liu C; Brill KL; Rosenberg AL; Witkiewicz AK; Rui H
    Cancer Res; 2010 Feb; 70(4):1711-21. PubMed ID: 20124477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcription factor signal transducer and activator of transcription 5 promotes growth of human prostate cancer cells in vivo.
    Dagvadorj A; Kirken RA; Leiby B; Karras J; Nevalainen MT
    Clin Cancer Res; 2008 Mar; 14(5):1317-24. PubMed ID: 18316550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signal transducer and activator of transcription-5 activation and breast cancer prognosis.
    Nevalainen MT; Xie J; Torhorst J; Bubendorf L; Haas P; Kononen J; Sauter G; Rui H
    J Clin Oncol; 2004 Jun; 22(11):2053-60. PubMed ID: 15169792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-overexpression of Janus kinase 2 and signal transducer and activator of transcription 5a promotes differentiation of mammary cancer cells through reversal of epithelial-mesenchymal transition.
    Sultan AS; Brim H; Sherif ZA
    Cancer Sci; 2008 Feb; 99(2):272-9. PubMed ID: 18271926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic utility of phosphorylated signal transducer and activator of transcription 5 immunostaining in the diagnosis of mammary analogue secretory carcinoma of the salivary gland: A comparative study of salivary gland cancers.
    Kawahara A; Taira T; Abe H; Takase Y; Kurita T; Sadashima E; Hattori S; Imamura I; Matsumoto S; Fujisaki H; Sueyoshi K; Akiba J; Kage M
    Cancer Cytopathol; 2015 Oct; 123(10):603-11. PubMed ID: 26252941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serine residues 726 and 780 have nonredundant roles regulating STAT5a activity in luminal breast cancer.
    Woock AE; Grible JM; Olex AL; Harrell JC; Zot P; Idowu M; Clevenger CV
    Sci Rep; 2021 Jun; 11(1):13506. PubMed ID: 34188118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HDAC6 Deacetylates HMGN2 to Regulate Stat5a Activity and Breast Cancer Growth.
    Medler TR; Craig JM; Fiorillo AA; Feeney YB; Harrell JC; Clevenger CV
    Mol Cancer Res; 2016 Oct; 14(10):994-1008. PubMed ID: 27358110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAT5 isoforms regulate colorectal cancer cell apoptosis via reduction of mitochondrial membrane potential and generation of reactive oxygen species.
    Du W; Wang YC; Hong J; Su WY; Lin YW; Lu R; Xiong H; Fang JY
    J Cell Physiol; 2012 Jun; 227(6):2421-9. PubMed ID: 21826656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STAT5A is regulated by DNA damage via the tumor suppressor p53.
    Mukhopadhyay UK; Cass J; Raptis L; Craig AW; Bourdeau V; Varma S; SenGupta S; Elliott BE; Ferbeyre G
    Cytokine; 2016 Jun; 82():70-9. PubMed ID: 26876578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of STAT5a by Naa10p contributes to decreased breast cancer metastasis.
    Zeng Y; Min L; Han Y; Meng L; Liu C; Xie Y; Dong B; Wang L; Jiang B; Xu H; Zhuang Q; Zhao C; Qu L; Shou C
    Carcinogenesis; 2014 Oct; 35(10):2244-53. PubMed ID: 24925029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stat5a is tyrosine phosphorylated and nuclear localized in a high proportion of human breast cancers.
    Cotarla I; Ren S; Zhang Y; Gehan E; Singh B; Furth PA
    Int J Cancer; 2004 Feb; 108(5):665-71. PubMed ID: 14696092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcription factor Stat5 synergizes with androgen receptor in prostate cancer cells.
    Tan SH; Dagvadorj A; Shen F; Gu L; Liao Z; Abdulghani J; Zhang Y; Gelmann EP; Zellweger T; Culig Z; Visakorpi T; Bubendorf L; Kirken RA; Karras J; Nevalainen MT
    Cancer Res; 2008 Jan; 68(1):236-48. PubMed ID: 18172316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin Drives a Dynamic STAT5A/HDAC6/HMGN2 Cis-Regulatory Landscape Exploitable in ER+ Breast Cancer.
    Craig JM; Turner TH; Harrell JC; Clevenger CV
    Endocrinology; 2021 May; 162(5):. PubMed ID: 33589921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.